Cargando…

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?

Detalles Bibliográficos
Autores principales:	Gurbel, Paul A., Bliden, Kevin, Fletcher, Elizabeth, Tantry, Udaya, Kuliopulos, Athan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091401/ http://dx.doi.org/10.1016/S0735-1097(21)04483-1

Ejemplares similares

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

Further evidence for the use of aspirin in COVID-19
por: Tantry, Udaya S., et al.
Publicado: (2022)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19
por: Meloche, Chelsea, et al.
Publicado: (2021)

OUTCOMES OF ATTEMPTED RESUSCITATION WITH ACLS IN COVID-19 PATIENTS REQUIRING ICU ADMISSION
por: Khorsandi, Michael, et al.
Publicado: (2023)

A SYSTEMATIC REVIEW OF MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Dong, Vinh S., et al.
Publicado: (2022)

EVALUATION OF MICROVASCULAR FUNCTION AND SYSTEMIC INFLAMMATION IN THE ACUTE PHASE OF COVID-19 AND 1 YEAR AFTER RECOVERY: INSIGHTS INTO THE PATHOPHYSIOLOGY OF POST-COVID-19 SYNDROME
por: De Lorenzo, Andrea, et al.
Publicado: (2022)

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH
por: Raghunathan, Sahana, et al.
Publicado: (2022)

MORTALITY IN LATINOS WITH COVID-19, UNIVERSITY OF MIAMI EXPERIENCE
por: Montanez-Valverde, Raul A., et al.
Publicado: (2021)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

CORONARY ARTERY CALCIFICATION HERALDS ADVERSE CLINICAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19
por: Shabbir, Muhammad Asim, et al.
Publicado: (2021)

CARDIOVASCULAR IMPACT OF COVID-19 AMONG HOSPITALIZED US ACTIVE-DUTY SERVICE MEMBERS
por: McClelland, Patton, et al.
Publicado: (2023)

SURVIVAL OUTCOMES OF PEDIATRIC PATIENTS WITH COVID-19 INFECTION AND IN-HOSPITAL CARDIOPULMONARY RESUSCITATION
por: El-Zein, Rayan, et al.
Publicado: (2022)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY
por: Sammour, Yasser, et al.
Publicado: (2022)

TRENDS IN ACUTE CARDIOVASCULAR DISEASE ADMISSIONS BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC SURGE IN BOSTON
por: Diamond, Jamie Elizabeth, et al.
Publicado: (2021)

INITIAL SINGLE CENTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION EXPERIENCE IN NEW YORK BEFORE AND DURING THE COVID-19 PANDEMIC
por: Medranda, Giorgio, et al.
Publicado: (2021)

OUTCOMES FOLLOWING TELEHEALTH VISITS DURING THE COVID-19 PANDEMIC IN AN ADVANCED HEART FAILURE PRACTICE
por: Sayer, Gabriel, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

QT INTERVAL PROLONGATION IS A NOVEL PREDICTOR OF 1-YEAR MORTALITY IN PATIENTS WITH COVID-19 INFECTION
por: Banai, Ariel, et al.
Publicado: (2022)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

OUTCOME IMPLICATIONS OF PERICARDIAL EFFUSION IN PATIENTS ADMITTED WITH COVID-19: A MULTICENTER CLINICAL AND CT STUDY
por: Ruiz, Gabriel S., et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

TRENDS IN LONG-TERM CARDIOVASCULAR-RELATED HOSPITAL ADMISSIONS AFTER COVID-19 HOSPITALIZATION
por: Fontana, Gregory Paul, et al.
Publicado: (2023)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

EFFECT OF STATIN IN HOSPITALIZED PATIENTS WITH COVID 19
por: Bonilla, Hilda Mariana Gonzalez, et al.
Publicado: (2021)

CARDIAC ABNORMALITIES IN COVID-19 AND RELATIONSHIP TO OUTCOME
por: Krishna, Hema, et al.
Publicado: (2021)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

TAKOTSUBO SYNDROME FROM COVID-19 INFECTION
por: Kanelidis, Anthony, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

INFLAMMATION AND VASCULAR REMODELING IN COVID-19 HEARTS
por: Werlein, Christopher, et al.
Publicado: (2022)

TREATMENT OF MECHANICAL COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION DURING THE COVID-19 ERA: A COMPARISON WITH THE PRE-COVID-19 PERIOD
por: Spadaccio, Cristiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48vrkk3tnds7u114s85gtcqmvk